13F Holdings
中文EN

HNGE Hinge Health, Inc.

Services-Computer Processing & Data Preparation · NYSE · SEC CIK 1673743 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY49.9%
TTM net income YoY131.6%
TTM EPS YoY146.9%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin85.7%
Operating margin18.7%
Net margin21.0%
FCF margin40.2%
EBITDA margin19.1%

Returns

ROE66.3%
ROA20.5%
ROIC (approx.)869.6%
Asset turnover0.97x

Leverage & solvency

Liabilities / assets65.7%
Debt / equity0.00x
Current ratio1.04x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.92x
Accruals ratio-18.8%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31
Income statement
Revenue$587.86M$390.40M$292.73M
Cost of revenue$119.64M$90.50M$98.55M
Gross profit$468.22M$299.90M$194.18M
R&D expense$368.14M$100.84M$110.06M
SG&A expense$329.50M$63.91M$67.02M
Operating income-$546.37M-$31.91M-$130.51M
Pretax income-$527.26M-$11.26M-$108.55M
Income tax$998,000$677,000-$405,000
Net income-$528.26M-$11.93M-$108.14M
EBITDA-$541.24M-$25.96M-$124.89M
EPS (basic)-7.77-0.88-8.31
EPS (diluted)-7.77-0.88-8.31
Weighted avg. shares (diluted)54.58M13.56M13.02M
Banking
Provision for credit losses$3.06M$5.41M$4.86M
Balance sheet
Cash & equivalents$208.00M$302.59M$234.95M
Short-term investments$155.87M$165.79M—
Receivables$66.06M$42.49M—
Inventory$15.64M$10.87M—
Current assets$533.90M$583.45M—
PP&E, net$10.49M$7.38M—
Goodwill$64.10M$61.61M—
Intangibles$2.51M$1.81M—
Total assets$744.76M$673.26M—
Current liabilities$362.41M$249.30M—
Total liabilities$366.23M$256.56M—
Shareholders' equity$178.66M-$434.57M-$423.99M
Shares outstanding016.38M—
Cash flow statement
Operating cash flow$171.44M$49.00M-$63.91M
Capital expenditure$708,000$1.04M$1.98M
Free cash flow$170.73M$47.96M-$65.89M
Investing cash flow-$113.76M$18.31M$1.50M
Financing cash flow-$150.47M-$2.20M-$3.00M
Depreciation & amortization$5.13M$5.95M$5.63M
Stock-based compensation$643.01M$739,000$1.65M
Share buybacks$65.03M$0$0

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.